2026-10-25
DNOW clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
NAS100 27,087 +1.72%
S&P 7,401 +0.65%
GOLD $4,073 −1.00%
BTC $75,828 −0.15%
VIX 24.55 −12.88%
latest tape · as of 20:03 UTC
The Screen · Industrials · Industrial Distribution
DNOW Inc.
DNOW · the NYSE · USD · Market cap $2.5B · 5,200 employees
DNOW Inc.
Not yet scored13.72 USD
Price as of 5 Nov 2026Daily close, not a live quote
Screened 2026-11-05 · the tape above runs as of 20:03 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price13.72 USD at the 5 Nov 2026 close
- Our value readUndervalued vs our fair value, as of 5 Nov 2026
- Our regime readAccumulation, as of 5 Nov 2026
- Ethical screenNot yet scored
- OptionsOpen interest leans heavily to calls (put/call 0.05)
- Last reviewed5 Nov 2026 (1 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
PRICE · ONE YEAR
Our fair-value range: $16.20 to $20.60, base estimate $17.74 (screen dated 2026-11-05).
- Trend Accumulation
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 0.05, read 2026-11-05
- Ethical screen not yet scored
Price13.72 USD
Fair value17.74
Ethical score70.0/100
Value readUndervaluedas of 5 Nov 2026
Our investment reviews on this name
2026-11-05Read Markdown15.37-10.7% to today ✓Accumulation gives way to Markdown after an 8% slide in 6 days
2026-10-30Read Accumulation16.66-17.6% to today Markdown gives way to Accumulation after an 11% rise in 12 days
2026-10-18Read Markdown15.02-8.7% to today ✓Accumulation gives way to Markdown after a 5% slide in 7 days
2026-10-11Read Accumulation15.88-13.6% to today Markdown gives way to Accumulation first Accumulation read since July
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
The full research record, in depth, below
This name holds its accumulation label.
DNOW Inc. holds its Accumulation at $13.72. Consolidating, no directional conviction, held for 40 days.
| Phase | Accumulation |
| Quantitative state | Consolidating, no directional conviction, held for 40 days |
| Price at the screen | $13.72 |
| Valuation | N/A trailing · 16.65 forward price to earnings |
| Values screen | Not scored · score 70.0 |
| Beta | 0.97 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 14.91% | Below 33% | Interest-bearing debt is just 14.9% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 26.45% | Below 49% | Money owed to the company is 26.5% of assets, under the 49% limit. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
DNOW clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
2026-09-24
Clears
DNOW clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 15%, inside the ~33% line, and almost none of its income is interest, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
What the Numbers Say It Is WorthThe Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 5 Nov 2026: it trades at roughly a 23% discount to our $17.74 fair value, 108.10% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-05 screen. The gold marker is the market price at the same screen. A 22.7% discount to the base estimate.
Third-party analyst targets. The average target sits +38% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere our models see it going: fair-value estimate $17.74, with a range of $16.20 to $20.60, dated to the 2026-11-05 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsOilfield Pipes Flow But Profits Do Not
Picture a rig crew in West Texas firing up pumps after a long slump. DNOW supplies the valves, pipes and pumps that keep those sites running. Revenue has jumped 98 percent as activity returns, yet the business still posts a negative 5 percent profit margin and negative 9 percent return on equity, so the recovery has not yet reached the bottom line.
We pass because the forward multiple of 16.5 times sits on still-loss-making operations in a sector that rises and falls with energy prices. Strong analyst targets around 16 dollars offer little comfort when earnings remain negative and the moat is unproven.
The real risk is the classic cyclical trap: peak activity can produce inflated numbers that later collapse, leaving investors with a low multiple on earnings that prove fleeting. Ethical screens clear, yet the numbers do not yet support ownership.
Analysis, not advice.
| Forward P/E | 16.7xcheap for a company growing this fast |
| EPS, trailing | -1.54 |
| EPS, forward | 0.82 |
| Revenue growth | +108.1%growing very fast |
| Profit margin | -4.6%currently unprofitable |
| Return on equity | -11.6%not currently earning a positive return on equity |
| FCF yield | -21.62% |
| Debt to equity | 0.31minimal debt: a conservative balance sheet |
| Current ratio | 2.14comfortably covers its short-term bills |
| Beta | 0.97steadier than the market |
| Short interest, float | 0.07% |
| 52-week range | 10.94 - 17.26 |
| Market cap | $2.5B |
| Employees | 5,200 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeDNOW trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
2026-11-05
Markdown · changed $15.37
-4.5% Entry 17
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 4.5% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (2 analysts) rates it strong buy, with a mean price target of $16. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-04
Accumulation $16.10
-1.3% Entry 16
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 1.3% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (2 analysts) rates it strong buy, with a mean price target of $16. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-03
Accumulation $16.31
+0.0% Entry 15
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (2 analysts) rates it strong buy, with a mean price target of $16. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-02
Accumulation $16.31
+0.0% Entry 14
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (2 analysts) rates it strong buy, with a mean price target of $16. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-01
Accumulation $16.31
-2.1% Entry 13
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 2.1% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (2 analysts) rates it strong buy, with a mean price target of $16. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-31
Accumulation $16.66
+0.0% Entry 12
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (2 analysts) rates it strong buy, with a mean price target of $16. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-30
Accumulation · changed $16.66
+6.2% Entry 11
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 6.2% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (2 analysts) rates it strong buy, with a mean price target of $16. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-29
Markdown $15.69
+1.8% Entry 10
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 1.8% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (2 analysts) rates it strong buy, with a mean price target of $16. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25
Markdown $15.41
+2.6% Entry 9
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 2.6% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (2 analysts) rates it strong buy, with a mean price target of $16.
2026-10-18
Markdown · changed $15.02
-5.4% Entry 8
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 5.4% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 7%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (2 analysts) rates it strong buy, with a mean price target of $16.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- DNOW Announces Third Quarter 2026 Earnings Conference Call Yahoo Finance · 10d ago
- DNOW (DNOW) Heads To Investor Conference, Is It Still 17% Below Fair Value? Yahoo Finance · 22 Sep 2026
- Nordson (NDSN) Down 6.9% Since Last Earnings Report: Can It Rebound? Zacks · 18 Sep 2026
- Nordson (NDSN) Down 6.9% Since Last Earnings Report: Can It Rebound? Yahoo Finance · 18 Sep 2026
- Is the Options Market Predicting a Spike in DNOW Stock? Zacks · 15 Sep 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
DXPEDXP Enterprises, Inc.
REZIResideo Technologies, Inc.
SITESiteOne Landscape Supply, Inc.
GICGlobal Industrial Company
DSGRDistribution Solutions Group, Inc.
XMTRXometry, Inc.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $13.13 | +5.4% | · | $1,054 | +5.4% |
| 2 months | $12.21 | +13.4% | · | $1,134 | +13.4% |
| 3 months | $11.29 | +22.6% | · | $1,226 | +22.6% |
| 6 months | $14.27 | -3.0% | · | $970 | -3.0% |
| 1 year | $14.87 | -6.9% | · | $931 | -6.9% |
| 2 years | $13.76 | +0.6% | · | $1,006 | +0.6% |
| 3 years | $10.09 | +37.2% | · | $1,372 | +37.2% |
| 5 years | $10.81 | +28.0% | · | $1,280 | +28.0% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever DNOW does next, these words stay.
Membership
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.